Volume 71, Issue 6, Pages (June 2017)

Slides:

Advertisements

Similar presentations

Photodynamic Laser Therapy for Lesions in the Airway

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 64, Issue 3, Pages (September 2013)

Volume 58, Issue 2, Pages (August 2010)

Testosterone Therapy in Men With Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 63, Issue 5, Pages (May 2013)

Volume 61, Issue 6, Pages (June 2012)

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Volume 70, Issue 6, Pages (December 2016)

Volume 60, Issue 2, Pages (August 2011)

Volume 199, Issue 4, Pages e235-e236 (April 2018)

European Urology Oncology

Volume 68, Issue 3, Pages (September 2015)

Volume 69, Issue 1, Pages (January 2016)

Volume 51, Issue 3, Pages (March 2007)

Volume 74, Issue 2, Pages (August 2018)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Ashish M. Kamat, Sima Porten European Urology

Volume 72, Issue 5, Pages (November 2017)

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Volume 61, Issue 4, Pages (April 2012)

Volume 72, Issue 5, Pages (November 2017)

Volume 63, Issue 4, Pages (April 2013)

Volume 63, Issue 1, Pages (January 2013)

European Urology Oncology

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 54, Issue 4, Pages (October 2008)

Volume 73, Issue 2, Pages (February 2018)

Volume 61, Issue 5, Pages (May 2012)

Volume 61, Issue 4, Pages (April 2012)

Volume 53, Issue 4, Pages (April 2008)

Volume 74, Issue 1, Pages (July 2018)

Volume 64, Issue 3, Pages (September 2013)

Volume 71, Issue 5, Pages (May 2017)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 2, Pages (February 2008)

Volume 64, Issue 4, Pages (October 2013)

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 6, Pages (June 2008)

Volume 66, Issue 6, Pages (December 2014)

Volume 66, Issue 6, Pages (December 2014)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Volume 65, Issue 4, Pages (April 2014)

The Economic Costs of Overactive Bladder in Germany

Volume 53, Issue 1, Pages (January 2008)

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 69, Issue 6, Pages (June 2016)

Volume 62, Issue 3, Pages (September 2012)

Volume 71, Issue 5, Pages (May 2017)

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Anthony Lemaire, MD, William R

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? Vincenzo Mirone

Volume 52, Issue 4, Pages (October 2007)

Volume 53, Issue 6, Pages (June 2008)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 52, Issue 1, Pages (July 2007)

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Presentation transcript:

Volume 71, Issue 6, Pages 952-960 (June 2017) Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, Andrzej Niemierko, Michael Drumm, Niall M. Heney, Marc D. Michaelson, Richard J. Lee, Philip J. Saylor, Matthew F. Wszolek, Adam S. Feldman, Douglas M. Dahl, Anthony L. Zietman, Jason A. Efstathiou European Urology Volume 71, Issue 6, Pages 952-960 (June 2017) DOI: 10.1016/j.eururo.2016.12.020 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 (A and B) Kaplan-Meier plots for rates of disease-specific survival and overall survival, respectively, for all patients; (C and D) stratified by clinical T2 versus T3/4a; (E and F) stratified by induction response status; and (G and H) stratified by extent of transurethral resection of bladder tumor (TURBT). CR=complete response. European Urology 2017 71, 952-960DOI: (10.1016/j.eururo.2016.12.020) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 (A) Improvements in overall survival, (B) disease-specific survival, and (C) bladder-intact disease-specific survival, with (D) a reduction in the crude rate of salvage cystectomy over three treatment eras. European Urology 2017 71, 952-960DOI: (10.1016/j.eururo.2016.12.020) Copyright © 2016 European Association of Urology Terms and Conditions